Half-year report · Q2
3939.TEDINET S100VQ7Q
Period2024-10-01 → 2025-03-31
Filed2025-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.7bn | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥5.0bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.4bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Operating income | ¥765m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥669m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥764m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥675m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥764m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥684m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥518m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥920m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥458m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥518m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥458m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥6.2bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥6.2bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥5.6bn | at 2024-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.1bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥2.3bn | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥4.1bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.8bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.4bn | at 2024-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.9bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.4bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2023-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥551m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.5bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥438m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥539m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥344m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥194m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥486m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥614m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥434m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥10.93 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.38 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.65 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 65.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.1% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-10-01 → 2025-03-31 | −¥18m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-10-01 → 2025-03-31 | −¥18m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥74m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥551m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥551m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥57m |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥1.8bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥1.8bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥5m |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥737m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥344m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥330m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥14m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥44m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-03-31 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-03-31 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥18m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-03-31 | ¥839m |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-03-31 | −¥5m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-03-31 | −¥5m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥21m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥613m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥613m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥15m |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥1.6bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥1.6bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥1m |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥641m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥285m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥281m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥4m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥34m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-03-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-03-31 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥5m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-03-31 | ¥690m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 536
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)猪俣 雅弘 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)川口 靖仁 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 2446366000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 2661188000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 5007468000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 675282000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 764435000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 1447993000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 458071000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 518485000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 919989000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 460651000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 519104000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 920961000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 3374504000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 4054275000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 3834813000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 5606868000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 6156984000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 6175564000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 9.65 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 10.93 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 19.38 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.602 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.658 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.621 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 438481000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 551497000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1514066000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -194314000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -538822000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -343844000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -433673000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -486194000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -613676000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 2685522000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 2947365000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 3430050000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 48132000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 48132000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 48132000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 48132000 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 13680000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.2882 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |